MX2021004383A - Composiciones y metodos para la estimulacion ovarica controlada. - Google Patents

Composiciones y metodos para la estimulacion ovarica controlada.

Info

Publication number
MX2021004383A
MX2021004383A MX2021004383A MX2021004383A MX2021004383A MX 2021004383 A MX2021004383 A MX 2021004383A MX 2021004383 A MX2021004383 A MX 2021004383A MX 2021004383 A MX2021004383 A MX 2021004383A MX 2021004383 A MX2021004383 A MX 2021004383A
Authority
MX
Mexico
Prior art keywords
methods
compositions
ovarian stimulation
controlled ovarian
controlled
Prior art date
Application number
MX2021004383A
Other languages
English (en)
Inventor
Lisbeth Helmgaard
Bjarke Mirner Klein
Saez Joan - Carles Arce
Patrick Heiser
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of MX2021004383A publication Critical patent/MX2021004383A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pregnancy & Childbirth (AREA)
  • Zoology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Se describen métodos que usan y composiciones que incluyen FSH para usarse en el tratamiento de la infertilidad, en los que la dosis se selecciona basándose en la edad de la paciente para optimizar la eficacia acumulativa y/o reducir el riesgo de OHSS.
MX2021004383A 2018-10-17 2019-10-17 Composiciones y metodos para la estimulacion ovarica controlada. MX2021004383A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862746812P 2018-10-17 2018-10-17
EP18203167 2018-10-29
PCT/EP2019/078170 WO2020079127A1 (en) 2018-10-17 2019-10-17 Compositions and methods for controlled ovarian stimulation

Publications (1)

Publication Number Publication Date
MX2021004383A true MX2021004383A (es) 2021-06-04

Family

ID=68344788

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021004383A MX2021004383A (es) 2018-10-17 2019-10-17 Composiciones y metodos para la estimulacion ovarica controlada.

Country Status (17)

Country Link
US (1) US20210353717A1 (es)
EP (1) EP3866833A1 (es)
JP (1) JP2022505191A (es)
KR (1) KR20210079276A (es)
CN (1) CN112789053A (es)
AU (1) AU2019363279A1 (es)
BR (1) BR112021005019A2 (es)
CA (1) CA3110205A1 (es)
CL (2) CL2021000928A1 (es)
CO (1) CO2021005872A2 (es)
IL (1) IL280750A (es)
JO (1) JOP20210025A1 (es)
MA (1) MA53909A (es)
MX (1) MX2021004383A (es)
PH (1) PH12021550417A1 (es)
SG (1) SG11202102340RA (es)
WO (1) WO2020079127A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL272763B2 (en) 2017-09-01 2024-02-01 Ferring Bv The composition for controlled stimulation of the ovary

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003022303A2 (en) * 2001-09-12 2003-03-20 Applied Research Systems Ars Holding N.V. Use of hcg and lh in controlled ovarian hyperstimulation
EP1364658A1 (en) * 2002-05-24 2003-11-26 Applied Research Systems ARS Holding N.V. Use of varying ratios of gonadotrophins in controlled ovarian hyperstimulation
TWI488640B (zh) 2008-04-16 2015-06-21 Ferring Int Ct Sa 藥學製劑
JO3092B1 (ar) 2011-08-08 2017-03-15 Ferring Bv مركب لتحفيز مسيطر عليه للمبيض

Also Published As

Publication number Publication date
CL2021000928A1 (es) 2021-10-22
MA53909A (fr) 2022-01-26
WO2020079127A1 (en) 2020-04-23
PH12021550417A1 (en) 2021-09-20
IL280750A (en) 2021-04-29
TW202027780A (zh) 2020-08-01
CO2021005872A2 (es) 2021-09-20
CL2022000779A1 (es) 2022-11-25
CN112789053A (zh) 2021-05-11
JP2022505191A (ja) 2022-01-14
AU2019363279A1 (en) 2021-03-11
CA3110205A1 (en) 2020-04-23
US20210353717A1 (en) 2021-11-18
SG11202102340RA (en) 2021-05-28
KR20210079276A (ko) 2021-06-29
BR112021005019A2 (pt) 2021-06-08
EP3866833A1 (en) 2021-08-25
JOP20210025A1 (ar) 2021-02-07

Similar Documents

Publication Publication Date Title
SA520412543B1 (ar) تركيبات وطرائق لعلاج السرطان والاضطرابات المناعية باستخدام جراثيم الفيونيلّة
MX2023007212A (es) Formulaciones de pulverizacion de epinefrina.
MX2021005398A (es) Terapia del cancer con celulas inmunitarias anti-cd33.
MX2019009227A (es) Métodos para tratar cáncer con inhibidores de hsp90.
MX2020008680A (es) Terapia de combinacion con apilimod y agentes glutamatergicos.
MX2019009190A (es) Uso de gaboxadol en el tratamiento de tinnitus.
CR20200546A (es) ESTIMULADOR SELECTIVO TREG RUR20kD-IL-2 Y COMPOSICIONES RELACIONADAS
CR20220329A (es) Anticuerpos anti–mertk y metodos de uso de los mismos
ZA201805358B (en) 3-(carboxymethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives
MX2022006073A (es) Metodos para utilizar anticuerpos anti-trem2.
MX2021013901A (es) Composiciones y métodos para el tratamiento del cáncer.
MX2021005400A (es) Terapia del cancer con celulas inmunitarias anti-ptk7.
JOP20210170A1 (ar) طرق وتركيبات لعلاج اضطرابات الجلد والشعر
MX2023010711A (es) Fenalquilaminas y métodos de preparación y uso de las mismas.
MX2021010665A (es) Metodos de tratamiento de amiloidosis al.
PH12021550417A1 (en) Compositions and methods for controlled ovarian stimulation
PH12021551235A1 (en) Elacestrant in combination with abemaciclib in women with breast cancer
WO2019040105A3 (en) COMPOUNDS, SALTS THEREOF AND METHODS FOR THE TREATMENT OF DISEASES
MX2022005250A (es) Combinaciones terapeuticas de acalabrutinib y capivasertib para tratar neoplasias malignas de linfocitos b.
EA202190891A1 (ru) Композиции и способы для контролируемой стимуляции яичников
MX2021005751A (es) Anticuerpos contra mucina 16 y métodos de uso de los mismos.
WO2019190927A3 (en) Splice-switching oligonucleotides and methods of use
MX2022006883A (es) Uso de isatuximab para el tratamiento del mieloma multiple recidivante y/o refractario.
MD3675894T2 (ro) Compoziție pentru stimularea ovariană controlată
MX2022013895A (es) Derivados de bexaroteno y su uso en el tratamiento del cancer.